|
|
|
篇目详细内容 |
|
【篇名】 |
Clinical and genetic risk factors for venous thromboembolism in Chinese population |
|
【刊名】 |
Frontiers of Medicine in China |
|
【刊名缩写】 |
Front. Med. China |
|
【ISSN】 |
1673-7342 |
|
【EISSN】 |
1673-7458 |
|
【DOI】 |
10.1007/s11684-010-0012-y |
|
【出版社】 |
Higher Education Press and Springer-Verlag Berlin
Heidelberg |
|
【出版年】 |
2010 |
|
【卷期】 |
4
卷1期 |
|
【页码】 |
29-35
页,共
7
页 |
|
【作者】 |
Chen WANG PhD, MD;
Zhen-Guo ZHAI PhD, MD;
Ying H. SHEN PhD, MD;
Lan ZHAO PhD, MD;
|
|
【关键词】 |
risk factor; stroke; prothrombin; plasminogen activator inhibitor type-1; polymorphism; thrombophilia; biomarker |
【摘要】 |
|
Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, carries significant mortality and morbidity. The most important and effective way to reduce VTE incidence is to identify the patients at risk and give necessary prevention. VTE is a multifactorial and complicated disorder. Major risk factors for VTE include surgery and trauma, acute medical illness, active cancer and pregnancy. Genetic factors increase susceptibility to the disease and are useful in predicting the development of VTE. Gene-gene and gene-environment interactions alter and magnify the clinical picture in this disorder. This brief review summarizes some selected clinical and genetic risk factors for VTE based on the current research in China. |
|
